These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8544455

  • 1. A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients.
    Kondo K, Tsuzuki H, Sasa M, Sumitomo M, Uyama T, Monden Y.
    J Surg Oncol; 1996 Jan; 61(1):20-6. PubMed ID: 8544455
    [Abstract] [Full Text] [Related]

  • 2. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 3. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
    Wang X, Christiani DC, Mark EJ, Nelson H, Wiencke JK, Gunn L, Wain JC, Kelsey KT.
    Cancer; 1999 Apr 15; 85(8):1734-9. PubMed ID: 10223567
    [Abstract] [Full Text] [Related]

  • 4. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.
    Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413
    [Abstract] [Full Text] [Related]

  • 5. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY, Chong IW, Chen FM, Wang JY, Cheng TL, Cheng YJ, Sheu CC, Hung SY, Yang MC, Lin SR.
    Cancer Lett; 2005 May 26; 222(2):195-204. PubMed ID: 15863268
    [Abstract] [Full Text] [Related]

  • 6. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
    Nelson HH, Christiani DC, Wiencke JK, Mark EJ, Wain JC, Kelsey KT.
    Cancer Res; 1999 Sep 15; 59(18):4570-3. PubMed ID: 10493509
    [Abstract] [Full Text] [Related]

  • 7. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K, Ishida H, Furukawa T, Koyanagi K, Miyamoto Y.
    Rinsho Byori; 1996 Jan 15; 44(1):32-41. PubMed ID: 8691638
    [Abstract] [Full Text] [Related]

  • 8. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H, Ogura T, Yokose T, Nagai K, Nishiwaki Y, Esumi H.
    Hum Pathol; 2001 Oct 15; 32(10):1043-9. PubMed ID: 11679937
    [Abstract] [Full Text] [Related]

  • 9. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.
    Murata M, Tagawa M, Kimura H, Kakisawa K, Shirasawa H, Fujisawa T.
    Int J Oncol; 1998 Mar 15; 12(3):577-81. PubMed ID: 9472095
    [Abstract] [Full Text] [Related]

  • 10. Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary.
    Anna L, Holmila R, Kovács K, Gyorffy E, Gyori Z, Segesdi J, Minárovits J, Soltész I, Kostic S, Csekeo A, Husgafvel-Pursiainen K, Schoket B.
    Mutagenesis; 2009 Nov 15; 24(6):475-80. PubMed ID: 19643813
    [Abstract] [Full Text] [Related]

  • 11. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T, Gemma A, Hosoya Y, Hosomi Y, Nara M, Kokubo Y, Yoshimura A, Shibuya M, Nagashima M, Harris CC, Kudoh S.
    Oncol Rep; 2006 Mar 15; 15(3):545-9. PubMed ID: 16465410
    [Abstract] [Full Text] [Related]

  • 12. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer].
    Gao ZQ, Gao Z, Zhang X.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar 15; 31(2):88-91. PubMed ID: 9812619
    [Abstract] [Full Text] [Related]

  • 13. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer.
    Ahrendt SA, Chow JT, Yang SC, Wu L, Zhang MJ, Jen J, Sidransky D.
    Cancer Res; 2000 Jun 15; 60(12):3155-9. PubMed ID: 10866304
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.
    Husgafvel-Pursiainen K, Boffetta P, Kannio A, Nyberg F, Pershagen G, Mukeria A, Constantinescu V, Fortes C, Benhamou S.
    Cancer Res; 2000 Jun 01; 60(11):2906-11. PubMed ID: 10850436
    [Abstract] [Full Text] [Related]

  • 17. Association between p53 gene mutations and tobacco and alcohol exposure in laryngeal squamous cell carcinoma.
    Ronchetti D, Neglia CB, Cesana BM, Carboni N, Neri A, Pruneri G, Pignataro L.
    Arch Otolaryngol Head Neck Surg; 2004 Mar 01; 130(3):303-6. PubMed ID: 15023836
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
    Saranath D, Tandle AT, Teni TR, Dedhia PM, Borges AM, Parikh D, Sanghavi V, Mehta AR.
    Oral Oncol; 1999 May 01; 35(3):242-50. PubMed ID: 10621843
    [Abstract] [Full Text] [Related]

  • 20. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T, Nelson HH, Ashok TD, Wain JC, Mark EJ, Christiani DC, Wiencke JK, Kelsey KT.
    Cancer Res; 2001 Jan 15; 61(2):612-5. PubMed ID: 11212258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.